SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-10-039961
Filing Date
2010-07-28
Accepted
2010-07-28 07:01:36
Documents
12
Period of Report
2010-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q a10-12648_110q.htm 10-Q 1370786
2 EX-12.1 a10-12648_1ex12d1.htm EX-12.1 78211
3 EX-31.1 a10-12648_1ex31d1.htm EX-31.1 12980
4 EX-31.2 a10-12648_1ex31d2.htm EX-31.2 13304
5 EX-32.1 a10-12648_1ex32d1.htm EX-32.1 6650
6 EX-32.2 a10-12648_1ex32d2.htm EX-32.2 6629
  Complete submission text file 0001104659-10-039961.txt   5822164

Data Files

Seq Description Document Type Size
7 EX-101.INS uthr-20100630.xml EX-101.INS 931506
8 EX-101.SCH uthr-20100630.xsd EX-101.SCH 18210
9 EX-101.CAL uthr-20100630_cal.xml EX-101.CAL 50047
10 EX-101.DEF uthr-20100630_def.xml EX-101.DEF 95938
11 EX-101.LAB uthr-20100630_lab.xml EX-101.LAB 255146
12 EX-101.PRE uthr-20100630_pre.xml EX-101.PRE 127734
Mailing Address 1040 SPRING ST SILVER SPRING MD 20910
Business Address 1040 SPRING ST SILVER SPRING MD 20910 3016089292
UNITED THERAPEUTICS Corp (Filer) CIK: 0001082554 (see all company filings)

IRS No.: 521984749 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-26301 | Film No.: 10972889
SIC: 2834 Pharmaceutical Preparations